Home › Funds › Vestal Point Capital, LP › ABVX

Vestal Point Capital, LP position in ABVX

ABIVAX SA · Health Care

Vestal Point Capital, LP reported holding 2,349,443 shares of ABVX (ABIVAX SA) in its Q2 2026 13F filing — a position valued at US$313.1M, representing 7.32% of its reported portfolio and ranking #3 among its reported holdings. Vestal Point Capital, LP has disclosed ABVX holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

Latest position (Q2 2026)2.35M sh
Reported value held$313.09M
Portfolio Weight7.32%
First reportedQ3 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Vestal Point Capital, LP's ABVX position evolved

Vestal Point Capital, LP first disclosed a stake in ABVX in Q3 2025 at 1,000,000 shares (US$84.9M). The position peaked in Q2 2026 at 2,349,443 shares, worth US$313.1M. Across 4 filings, Vestal Point Capital, LP increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 2,349,443 shares valued at US$313.1M — an increase of 849,443 shares quarter over quarter.. Notable position changes include a 90% increase in Q4 2025 (shares fell 17% over the following quarter), a 57% increase in Q2 2026 (shares fell 26% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 1.00M $84.90M New
Q4 2025 1.90M $256.22M Add
Q1 2026 1.50M $167.03M Reduce
Q2 2026 2.35M $313.09M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABVX and 13F data

ABVX (ABIVAX SA) is a Health Care company. 72 other funds we track also report a position in ABVX — the largest reported positions include TCG Crossover Management, LLC (US$800.6M), Helikon Investments Ltd (US$371.4M), Darwin Global Management, Ltd. (US$348.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABVX

All ABVX fund holders →

FAQ

How long has Vestal Point Capital, LP held ABVX?

Vestal Point Capital, LP has disclosed ABVX holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

What is Vestal Point Capital, LP's current position in ABVX?

As of Q2 2026, Vestal Point Capital, LP holds 2.35M shares of ABVX (ABIVAX SA), valued at $313.09M, representing 7.32% of its reported portfolio and ranking #3.

Has Vestal Point Capital, LP been buying or selling ABVX?

In the latest 13F filing (Q2 2026), Vestal Point Capital, LP increased its position in ABVX. The position peaked in Q2 2026 at 2.35M shares.

Which other funds hold ABVX?

Other major institutional holders of ABVX include TCG Crossover Management, LLC, Helikon Investments Ltd, Darwin Global Management, Ltd., among 72 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.